Engineering of vascular ingrowth matrices: Are protein domains an alternative to peptides?

Anatomical Record

Volumn 263, Issue 4, 2001, Pages 379-387

  Merzkirch, Christoph ^a   Davies, Neil ^a,b   Zilla, Peter ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GROWTH FACTOR; POLITEF; POLYSTYRENE;

ARTERY GRAFT; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL GRAFT; CELL ADHESION; CELL CULTURE; CELL MIGRATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOGENESIS; THROMBOSIS; VEIN GRAFT;

ANIMALS; BIOARTIFICIAL ORGANS; BIOMEDICAL ENGINEERING; BLOOD VESSELS; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; FIBRONECTINS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; VASCULAR SURGICAL PROCEDURES;

EID: 0035425284     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ar.1118     Document Type: Article

References (98)

1. Differential effects of platelet-derived growth factor BB on p125 focal adhesion kinase and paxillin tyrosine phosphorylation and on cell migration in rabbit aortic vascular smooth muscle cells and Swiss 3T3 fibroblasts
2. Signalling mechanisms in the regulation of vascular cell migration
3. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells
4. Differential expression of integrin cell-substratum adhesion receptors on endothelium
5. Integrins and other cell adhesion molecules
6. In vitro endothelialization of small-caliber vascular grafts
7. Anchorage-dependent cell cycle progression
8. Receptor tyrosine phosphatase beta is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin
9. Spatiotemporal segregation of endothelial cell integrin and nonintegrin extracellular matrix-binding proteins during adhesion events
10. Fibronectin and avidin-biotin as a heterogeneous ligand system for enhanced endothelial cell adhesion
11. Approaches to studying cel adhesion molecules in angiogenesis
12. Covalent attachment of an Arg-Gly-Asp sequence peptide to derivatizable polyacrylamide surfaces: Support of fibroblast adhesion and long-term growth
13. Focal adhesions, contractility, and signaling
14. Integrin-mediated cell adhesion activates mitogen-activated protein kinases
15. Alpha4beta1 and alpha5beta1 control cell migration on fibronectin by differentially regulating cell speed and motile cell phenotype
16. Polymer substrates for controlled biological interactions
17. Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix
18. Management of peripheral arterial disease
19. Syndecans, signaling, and cell adhesion
20. Signal transduction by integrin receptors for extracellular matrix: Cooperative processing of extracellular information
21. The lack of healing in conventional vascular grafts
22. Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: Correlation with Bcl-2 and Bax
23. Modulation of extracellular matrix receptors (integrins) on human endothelial cells by cytokines
24. Tumor necrosis factor alpha and interferon gamma modulate the expression of the vitronectin receptor (integrin beta 3) in human endothelial cells
25. In vitro endothelialization of expanded polytetrafluorethylene grafts: A clinical case report after 41 months of implantation
26. Multifunctional poly(ethylene glycol) semiinterpenetrating polymer networks as highly selective adhesive substrates for bioadhesive substrates for bioadhesive peptide grafting
27. Basic FGF and TGF-beta differentially modulate integrin expression of human microvascular endothelial cells
28. HA receptors: Regulators of signalling to the cytoskeleton
29. Adult human endothelial cell coverage of small-caliber Dacron and polytetrafluoroethylene vascular prostheses in vitro
30. Factors involved in the control of proliferation of bovine corneal endothelial cells maintained in serum-free medium
31. Matrix metalloproteinase expression in human retinal microvascular cells
32. Structural requirements for biological activity of the ninth and tenth FIII domains of human fibronectin
33. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment
34. Spatial and temporal changes in compliance following implantation of bioresorbable vascular grafts
35. Serial cultivation of adult human endothelium from the great saphenous vein
36. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing
37. Activation of distinct alpha5beta1-mediated signaling pathways by fibronectin's cell adhesion and matrix assembly domains
38. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor
39. Integrins: Versatility, modulation, and signaling in cell adhesion
40. Fibronectins
41. The role of integrins in saphenous vein vascular smooth muscle cell migration
42. In vitro lining of fibronectin coated PTFE grafts with cryopreserved saphenous vein endothelial cells
43. Precoating substrate and surface configuration determine adherence and spreading of seeded endothelial cells on polytetrafluoroethylene grafts
44. Extracellular matrix proteins are potent agonists of human smooth muscle cell migration
45. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells
46. Regulation of cell motility by mitogen-activated protein kinase
47. A completely biological tissue-engineered human blood vessel
48. Tissue engineering
49. Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms
50. Endothelial cell adhesion on polyurethanes containing covalently attached RGD-peptides
51. High and low molecular weight forms of endothelial cell growth factor
52. Prospective clinical study with in vitro endothelial cell lining of expanded polytetrafluoroethylene grafts in crural repeat reconstruction
53. Degradation of human plasma and extracellular matrix fibronectin by tissue type plasminogen activator and urokinase
54. Covalent surface immobilization of Arg-Gly-Asp- and Tyr-Ile-Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates
55. An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation
56. Interaction of the 70,000-mol-wt amino-terminal fragment of fibronectin with the matrix-assembly receptor of fibroblasts
57. Adhesion to fibronectin stimulates inositol lipid synthesis and enhances PDGF-induced inositol lipid breakdown
58. Eight years of clinical endothelial cell transplantation. Closing the gap between prosthetic grafts and vein grafts
59. Basic fibroblast growth factor induces angiogenesis in vitro
60. Physiology of fibronectin
61. Assembly of extracellular matrix
62. Stromelysin generates a fibronectin fragment that inhibits Schwann cell proliferation
63. Immediate shear stress resistance of endothelial cell monolayers seeded in vitro on fibrin glue-coated ePTFE prostheses
64. Platelet-derived growth factor and extracellular matrix proteins provide a synergistic stimulus for human vascular smooth muscle cell migration
65. Cell adhesive properties of bioelastic materials containing cell attachment sequences
66. Functional arteries grown in vitro
67. Amphibian neural crest cell migration on purified extracellular matrix components: A chondroitin sulfate proteoglycan inhibits locomotion on fibronectin substrates
68. Partial primary structure of bovine plasma fibronectin: Three types of internal homology
69. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
70. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex
71. Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment
72. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft
73. Fibronectin's amino-terminal matrix assembly site is located within the 29-kDa amino-terminal domain containing five type I repeats
74. Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells. Bell-shaped dose response and cross-talk with bombesin
75. Defining fibronectin's cell adhesion synergy site by site-directed mutagenesis
76. Integrin cytoplasmic domains: Mediators of cytoskeletal linkages and extra- and intracellular initiated transmembrane signaling
77. Focal adhesion kinase and associated proteins
78. Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin
79. Adhesion is required for protein kinase C-dependent activation of the Na+/H+ antiporter by platelet-derived growth factor
80. The cell binding domain of fibronectin is chemotactic for fibroblasts
81. Improved patency of collagen-impregnated grafts after in vitro autogenous endothelial cell seeding
82. Adhesion receptors of the immune system
83. Regulation of cell movement: The motogenic cytokines
84. On the crawling of animal cells
85. Cell surface adhesion molecules: Structure, function, clinical aspects
86. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: A potential angiogenesis regulatory factor
87. Adult human endothelial cell seeding using expanded polytetrafluoroethylene vascular grafts: A comparison of four substrates
88. Substrate-adsorbed collagen and cell secreted fibronectin concertedly induce cell migration on poly(lactide-glycolide) substrates
89. Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: Implications for tumor invasion
90. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions
91. Proteolytically degradable hydrogels
92. Fibronectin domains and receptors
93. Signaling mechanisms for vascular cell migration
94. Focal adhesion kinase (p125FAK): A point of convergence in the action of neuropeptides, integrins, and oncogenes
95. Cell motility and the extracellular matrix
96. Clinical in vitro endothelialization of femoropopliteal bypass grafts: An actuarial follow-up over three years
97. In situ cannulation, microgrid follow-up and low-density plating provide first passage endothelial cell masscultures for in vitro lining
98. Use of fibrin glue as a substrate for in vitro endothelialization of PTFE vascular grafts